Beeline Medicines: Funding, Investors & Team (Oct 2026)
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Beeline Medicines has raised $426M across 2 funding rounds on record, the most recent a Series A of $126M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Beeline Medicines Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Beeline Medicines Funding Rounds
Beeline Medicines raised $300M in a Series A announced in Apr 2026.
2 months later, a Series A of $126M was announced in Jun 2026.
Beeline Medicines Founders and Leadership Team
No contact details are on record for this team yet.
Beeline Medicines Funding Compared to Other Biotechnology Startups
Beeline Medicines' latest round of $126M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Beeline Medicines in Biotechnology and Boston
Companies Similar to Beeline Medicines
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Beeline Medicines Funding FAQs
What does Beeline Medicines do?
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
How much funding has Beeline Medicines raised?
Beeline Medicines has raised $426M across 2 rounds on record. The most recent is a Series A of $126M announced in Jun 2026.
When did Beeline Medicines last raise funding?
Beeline Medicines' most recent funding round on record is a Series A of $126M, announced in Jun 2026.
Who founded Beeline Medicines?
FundedIQ lists Saqib Islam (Founder) at Beeline Medicines.
Where is Beeline Medicines headquartered?
Beeline Medicines is based in Boston, Massachusetts, United States.
How many employees does Beeline Medicines have?
Beeline Medicines is in the 11-50 employee band.
How does Beeline Medicines' funding compare to other Biotechnology startups?
Beeline Medicines' latest round of $126M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Beeline Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Beeline Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.